Clinical Trials Browser

Phase 2 × Completed × envafolimab × Clear all

NCT05068427 2024-08-07

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung